ABL Bio
Business Services · South Korea · 51-200 Employees
View Company Info for Free
Overview
Headquarters
16 Daewangpangyo-ro Fl 2 712, Seongnam-s...Phone Number
+82 3180189800Website
www.ablbio.comRevenue
$14.4 MillionIndustry
About ABL Bio
ABL Bio Org Chart
Is ABL Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
ABL Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Check if ABL Bio has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at ABL Bio
Product Launch: Get notified when ABL Bio launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on ABL Bio recently announced quarterly report
Funding: Get notified immidiatlly once ABL Bio has new funding data
Click to see if ABL Bio had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check out if ABL Bio is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
ABL Bio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
ABL Bio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about ABL Bio.
ABL Bio Tech Stack
A closer look at the technologies used by ABL Bio
Most Recent Scoops
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding ABL Bio
ABL Bio is a research-led biotechnology company, a pioneer in bispecific antibodies for immuno-oncology and neurodegenerative diseases. Delivering new approaches to address the highest unmet needs, the company is committed to improving the lives of people all over the world.... Read More
